Relief Therapeutics Holding SA (OTCMKTS:RLFTF) Sees Large Increase in Short Interest

Relief Therapeutics Holding SA (OTCMKTS:RLFTF) was the target of a large increase in short interest during the month of May. As of May 29th, there was short interest totaling 40,237 shares, an increase of 83.8% from the May 14th total of 21,893 shares. Based on an average daily volume of 4,758 shares, the short-interest ratio is presently 8.5 days.

Relief Therapeutics Stock Performance

Shares of OTCMKTS RLFTF traded down $0.04 during midday trading on Monday, reaching $0.35. 3,005 shares of the company were exchanged, compared to its average volume of 3,300. The stock’s 50-day moving average price is $0.45 and its 200-day moving average price is $1.33. Relief Therapeutics has a one year low of $0.33 and a one year high of $4.88.

About Relief Therapeutics

Relief Therapeutics AG is a clinical‐stage biopharmaceutical company focused on the development of novel therapies for rare and critical care indications. Headquartered in Geneva, Switzerland, the company leverages its expertise in peptide biology to address diseases with high unmet need, including acute respiratory distress syndrome (ARDS) and other serious pulmonary and inflammatory conditions.

The company’s lead product candidate, RLF‐100 (aviptadil), is a synthetic formulation of vasoactive intestinal peptide (VIP) being evaluated for the treatment of ARDS and COVID-19–associated respiratory failure.